Stocks / Biotech

IO Biotech Stock (IOBT): Opinions on Phase 3 Clinical Trial Risks

Recent online discussions regarding IO Biotech (IOBT) revolve around the high-stakes Phase 3 clinical trials and the company's financial stability. The outcome of these trials could significantly impact the stock price, with concerns raised...